← Leaderboards
Sriram Venneti
Sloan-Kettering Inst Can Research
$4,778,176
Attributed
$6,351,359
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,351,359 · 4
By mechanism
R01$5,650,154 · 3
K08$701,205 · 1
Top collaborators
- Deepak Nagrath4 shared
- Benita Tamrazi4 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Ingo K Mellinghoff$6,692,369
- Craig B Thompson$56,520,903
- Timothy An-Thy Chan$21,076,830
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMetabolic PathwayCellsEffective TherapyMetabolicOncogenesPathway InteractionsMetabolismTumorNutrient MetabolismIn VitroIn VivoGeneticCitric Acid CycleProductionPathogenesisEnzymesMutationUptakePositron-Emission TomographyGlutamineMouse ModelClinical TrialsChild
Grant awards (18)
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$596,380
R01 · FY2025 · CA · contact PI
Targeting metabolic dependencies in ZFTA-RELA fusion childhood ependymomas$588,332
R01 · FY2024 · NS · contact PI
Unravelling metabolic dependencies in H3K27M mutant DIPG$579,165
R01 · FY2024 · NS · contact PI
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$567,330
R01 · FY2024 · CA · contact PI
Targeting metabolic dependencies in ZFTA-RELA fusion childhood ependymomas$618,755
R01 · FY2023 · NS · contact PI
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$585,078
R01 · FY2023 · CA · contact PI
Unraveling metabolic dependencies in H3K27M mutant Diffuse Intrinsic Pontine Gliomas$300,196
R01 · FY2023 · NS · contact PI
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$610,986
R01 · FY2022 · CA · contact PI
Unraveling metabolic dependencies in H3K27M mutant Diffuse Intrinsic Pontine Gliomas$300,527
R01 · FY2022 · NS · contact PI
Unraveling metabolic dependencies in H3K27M mutant Diffuse Intrinsic Pontine Gliomas$300,840
R01 · FY2021 · NS · contact PI
Unraveling metabolic dependencies in H3K27M mutant Diffuse Intrinsic Pontine Gliomas$301,140
R01 · FY2020 · NS · contact PI
Unraveling metabolic dependencies in H3K27M mutant Diffuse Intrinsic Pontine Gliomas$301,425
R01 · FY2019 · NS · contact PI
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods$140,454
K08 · FY2018 · CA · contact PI
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods$140,454
K08 · FY2017 · CA · contact PI
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods$140,454
K08 · FY2016 · CA · contact PI
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods$140,454
K08 · FY2015 · CA · contact PI
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods$80,118
K08 · FY2014 · CA · contact PI
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods$59,271
K08 · FY2014 · CA · contact PI